These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Stone LA; Frank JA; Albert PS; Bash C; Smith ME; Maloni H; McFarland HF Ann Neurol; 1995 May; 37(5):611-9. PubMed ID: 7755356 [TBL] [Abstract][Full Text] [Related]
6. Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells. Trojano M; Defazio G; Avolio C; Paolicelli D; Giuliani F; Giorelli M; Livrea P J Neurovirol; 2000 May; 6 Suppl 2():S47-51. PubMed ID: 10871785 [TBL] [Abstract][Full Text] [Related]
7. Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis. Graber J; Zhan M; Ford D; Kursch F; Francis G; Bever C; Panitch H; Calabresi PA; Dhib-Jalbut S J Neuroimmunol; 2005 Apr; 161(1-2):169-76. PubMed ID: 15748956 [TBL] [Abstract][Full Text] [Related]
8. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis. Rieckmann P; Altenhofen B; Riegel A; Kallmann B; Felgenhauer K Mult Scler; 1998 Jun; 4(3):178-82. PubMed ID: 9762670 [TBL] [Abstract][Full Text] [Related]
9. Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b. Jensen J; Krakauer M; Sellebjerg F Cytokine; 2005 Jan; 29(1):24-30. PubMed ID: 15579375 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial. Minagar A; Alexander JS; Schwendimann RN; Kelley RE; Gonzalez-Toledo E; Jimenez JJ; Mauro L; Jy W; Smith SJ Arch Neurol; 2008 Feb; 65(2):199-204. PubMed ID: 18071030 [TBL] [Abstract][Full Text] [Related]
11. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Smith ME; Stone LA; Albert PS; Frank JA; Martin R; Armstrong M; Maloni H; McFarlin DE; McFarland HF Ann Neurol; 1993 May; 33(5):480-9. PubMed ID: 8498825 [TBL] [Abstract][Full Text] [Related]
20. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Leppert D; Waubant E; Bürk MR; Oksenberg JR; Hauser SL Ann Neurol; 1996 Dec; 40(6):846-52. PubMed ID: 9007089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]